Mercator Medical (FRA:MM2) ROC (Joel Greenblatt) %: 7.99% (As of Mar. 2026) — 39% Above Median


FRA:MM2 Mercator Medical SA FRA:MM2
59 GF Score
Price €11.20
GF Value €10.65
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Mercator Medical ROC (Joel Greenblatt) %?

Mercator Medical FRA:MM2 +1.79% 59 ROC (Joel Greenblatt) % is 7.99% as of Mar. 2026, which is 39% above its 10-year median of 5.74. GuruFocus rates FRA:MM2 with a GF Score™ of 59/100 and a GF Value™ of €10.65 (Fairly Valued). The stock has 2 warning signs investors should review. Among 840 Medical Devices & Instruments companies, Mercator Medical ranks worse than 50.71% on this metric.

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Mercator Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 7.99%.

The historical rank and industry rank for Mercator Medical's ROC (Joel Greenblatt) % or its related term are showing as below:

FRA:MM2' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -34.4   Med: 5.74   Max: 281.43
Current: 3.5

During the past 13 years, Mercator Medical's highest ROC (Joel Greenblatt) % was 281.43%. The lowest was -34.40%. And the median was 5.74%.

FRA:MM2's ROC (Joel Greenblatt) % is ranked worse than
50.71% of 840 companies
in the Medical Devices & Instruments industry
Industry Median: 4.035 vs FRA:MM2: 3.50

Mercator Medical's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.


Mercator Medical  (FRA:MM2) ROC (Joel Greenblatt) % Explanation

The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.

Joel Greenblatt uses his definition of Return on Capital and Earnings Yield (Joel Greenblatt) % to rank companies.


Mercator Medical ROC (Joel Greenblatt) % Related Terms


Mercator Medical ROC (Joel Greenblatt) % Historical Data

* Premium members only.

The historical data trend for Mercator Medical's ROC (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercator Medical ROC (Joel Greenblatt) % Chart

Mercator Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROC (Joel Greenblatt) %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.80 -34.40 -0.63 7.35 5.32

Mercator Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROC (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.69 -4.17 3.98 6.50 7.99

FRA:MM2 vs ISRG, BDX, MDLN: ROC (Joel Greenblatt) % Comparison

For the Medical Instruments & Supplies subindustry, Mercator Medical's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercator Medical ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's ROC (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where Mercator Medical's ROC (Joel Greenblatt) % falls into.


FRA:MM2
59GF Score
Mercator Medical SA FRA:MM2
ROC (Joel Greenblatt) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercator Medical ROC (Joel Greenblatt) % Calculation

Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:

ROC (Joel Greenblatt) %=EBIT/Average of (Net fixed Assets + Net Working Capital)

EBIT stands for Earnings Before Interest and Taxes.

Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.

GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(23.137 + 43.99 + 0.56700000000001) - (16.066 + 0 + 4.741)
=46.887

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(22.046 + 41.845 + 2.941) - (15.82 + 0 + 5.301)
=45.711

When net working capital is negative, 0 is used.

So ROC (Joel Greenblatt) % of Mercator Medical for the quarter that ended in Mar. 2026 can be restated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=10.032/( ( (79.167 + max(46.887, 0)) + (79.419 + max(45.711, 0)) )/ 2 )
=10.032/( ( 126.054 + 125.13 )/ 2 )
=10.032/125.592
=7.99 %

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROC (Joel Greenblatt) % of 7.99% mean?
Mercator Medical (FRA:MM2) has a ROC (Joel Greenblatt) % of 7.99% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Mercator Medical and its competitors. This is 39% above median its historical median of 5.74. According to the industry distribution chart, Mercator Medical ranks #426 out of 840 companies in the Medical Devices & Instruments industry, placing it in the top 50.7%.
Is Mercator Medical's ROC (Joel Greenblatt) % too high?
Mercator Medical's current ROC (Joel Greenblatt) % of 7.99% is 39% above median its 10-year median of 5.74. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.04. Mercator Medical's value of 7.99% is 98% above this industry median. Based on the distribution chart, Mercator Medical ranks #426 out of 840 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Mercator Medical has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's ROC (Joel Greenblatt) % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #426 out of 840 companies for ROC (Joel Greenblatt) %. This places Mercator Medical in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.04. Mercator Medical's value of 7.99% is 98% above this benchmark. While the company's 10-year median is 5.74 vs. the industry median of 4.04, Mercator Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.04, based on 840 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current ROC (Joel Greenblatt) % of 7.99% is 98% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Mercator Medical and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current ROC (Joel Greenblatt) % is 7.99%, which is 39% above median its own 10-year median of 5.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €10.65, compared to a current price of €11.20 — trading 5.2% above its estimated fair value. The current ROC (Joel Greenblatt) % is 7.99%, which is 39% above median its 10-year median of 5.74 and 98% above the Medical Devices & Instruments industry median of 4.04. Mercator Medical's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current ROC (Joel Greenblatt) % is 7.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercator Medical (FRA:MM2) Overvalued in 2026?

Based on GuruFocus' analysis, Mercator Medical stock appears to be overvalued. The current stock price of €11.20 is trading 5.2% above its estimated GF Value™ of €10.65. GuruFocus considers Mercator Medical to be Fairly Valued.

Key valuation signals for FRA:MM2:

  • ROC (Joel Greenblatt) %: 7.99% (39% above median its 10-year median of 5.74)
  • GF Value™: €10.65 vs. price of €11.20 (5.2% above fair value)
  • GF Score™: 59/100 with 2 warning signs
  • Industry Position: 98% above the Medical Devices & Instruments median (#426 of 840)

No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mercator Medical Business Description

Other Exchanges MRC:Poland
Address Ulica H. Modrzejewska 30, Krakow, POL, 31-327
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
59GF Score

Get the complete analysis for FRA:MM2

ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.20
Price
€10.65
GF Value